340 related articles for article (PubMed ID: 2873379)
1. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Lancet; 1986 Jul; 2(8498):57-66. PubMed ID: 2873379
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Lancet; 1988 Aug; 2(8607):349-60. PubMed ID: 2899772
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.
Lancet; 1988 Apr; 1(8591):921-3. PubMed ID: 2895838
[TBL] [Abstract][Full Text] [Related]
4. ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.
Lancet; 1992 Mar; 339(8796):753-70. PubMed ID: 1347801
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
J Am Coll Cardiol; 1988 Dec; 12(6 Suppl A):3A-13A. PubMed ID: 2903874
[TBL] [Abstract][Full Text] [Related]
6. Beta blockade early in acute myocardial infarction.
Sleight P
Am J Cardiol; 1987 Jul; 60(2):6A-10A. PubMed ID: 2887100
[TBL] [Abstract][Full Text] [Related]
7. Use of beta adrenoceptor blockade during and after acute myocardial infarction.
Sleight P
Annu Rev Med; 1986; 37():415-25. PubMed ID: 2871805
[TBL] [Abstract][Full Text] [Related]
8. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
Lancet; 1995 Mar; 345(8951):669-85. PubMed ID: 7661937
[TBL] [Abstract][Full Text] [Related]
9. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
Chen ZM; Pan HC; Chen YP; Peto R; Collins R; Jiang LX; Xie JX; Liu LS;
Lancet; 2005 Nov; 366(9497):1622-32. PubMed ID: 16271643
[TBL] [Abstract][Full Text] [Related]
10. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.
Yusuf S; Ramsdale D; Peto R; Furse L; Bennett D; Bray C; Sleight P
Lancet; 1980 Aug; 2(8189):273-6. PubMed ID: 6105436
[TBL] [Abstract][Full Text] [Related]
11. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
[TBL] [Abstract][Full Text] [Related]
12. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction. ISIS (International Studies of Infarct Survival) pilot study.
Eur Heart J; 1987 Jun; 8(6):634-42. PubMed ID: 2887430
[TBL] [Abstract][Full Text] [Related]
13. Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction.
Rossi PR; Yusuf S; Ramsdale D; Furze L; Sleight P
Br Med J (Clin Res Ed); 1983 Feb; 286(6364):506-10. PubMed ID: 6186329
[TBL] [Abstract][Full Text] [Related]
14. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
Yusuf S; Sleight P; Rossi P; Ramsdale D; Peto R; Furze L; Sterry H; Pearson M; Motwani R; Parish S; Gray R; Bennett D; Bray C
Circulation; 1983 Jun; 67(6 Pt 2):I32-41. PubMed ID: 6851037
[TBL] [Abstract][Full Text] [Related]
15. Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.
Coletta C; Ricci R; Ceci V; Seccareccia F; Rulli F; Mazzuca V; Putini RL; Salustri A; Bottero G; Pasquale M
G Ital Cardiol; 1999 Feb; 29(2):115-24; discussion 125-9. PubMed ID: 10088066
[TBL] [Abstract][Full Text] [Related]
16. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.
Eur Heart J; 1985 Mar; 6(3):199-226. PubMed ID: 2863148
[TBL] [Abstract][Full Text] [Related]
17. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.
Lancet; 1997 May; 349(9065):1569-81. PubMed ID: 9174558
[TBL] [Abstract][Full Text] [Related]
18. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
Baigent C; Collins R; Appleby P; Parish S; Sleight P; Peto R
BMJ; 1998 May; 316(7141):1337-43. PubMed ID: 9563981
[TBL] [Abstract][Full Text] [Related]
19. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.
Lancet; 1997 Jun; 349(9066):1641-9. PubMed ID: 9186381
[TBL] [Abstract][Full Text] [Related]
20. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
